SARAH MILLER: Open Payments
NPI 1508384488 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 27 payments from 7 companies in 2025. Trend: 2023 $1,007 · 2024 $984 · 2025 $773
Food & beverage: $596Gift: $176
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $281 |
| ViiV Healthcare Company | 4 | $240 |
| ABBVIE INC. | 9 | $135 |
| Antares Pharma, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: CABENUVA, Yeztugo, VRAYLAR, MAVYRET, XYOSTED, CAPLYTA, DOVATO, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
